Sign in →

Test Code LABMDDNAONCO DNA OncoPlus PBBM

Specimen and Container/Tube

Specimen Type: Peripheral Blood / Bone Marrow Aspirates
Preferred Specimen: lavendar top (EDTA).
Other Acceptable Specimens: N/A

Volume

Preferred Volume: 3 mL
Minimum Volume: 3 mL

Specimen Stability

Blood and bone marrow aspirate specimens may be kept at room temperature for up to 6 hours following collection, or at 4°C for up to two weeks

Collection Instructions

Collect specimen per standard laboratory collection procedures.

Specimen Handling and Transport Instructions

UCM Onsite Instructions: Collect specimen per standard collection procedured and send to the laboratory immediately.

Turnaround Time

Turnaround times are relative to the time the specimen is received in the testing laboratory section.

STAT Turnaround Time: n/a
Routine Turnaround Time: ≤14 Days

Testing Schedule: M-F 7:00am-5:00pm

Clinical Indications

The OncoPlus panel is a universal cancer mutation, next generation sequencing (NGS) assay that has the capability to cover more than 1,005 cancer-related genes, of which 168 genes are clinically reported, for personalized assessments of both solid tumors and hematological malignancies. Additional reportable features include tumor mutational burden (TMB), microsatellite stability status, and copy number alterations.

Test Components

Genes analyzed for mutations and insertions/deletions (168): ABL1, AKT1, ALK, APC, ARID1A, ARID2, ASXL1, ATM, ATR, ATRX, AXL, B2M, BAP1, BCOR, BCORL1, BIRC3, BLM, BRAF, BRCA1, BRCA2, BTK, CALR, CBL, CBLB, CCND1, CCND2, CCND3, CCNE1, CD274, CDH1, CDK4, CDK6, CDK12, CDKN2A, CEBPA, CHEK1, CHEK2, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUX1, CXCR4, DAXX, DDR2, DDX3X, DDX41, DICER1, DNMT3A, EGFR, ELOC, EP300, EPHA3, EPHA5, ERBB2, ERBB3, ERBB4, ERCC3, ESR1, ETV6, EZH2, FANCA, FAT3, FBXW7, FGFR1, FGFR2, FGFR3, FH, FLT3, FOXL2, GATA1, GATA2, GNA11, GNAQ, GNAS, GRIN2A, H3-3A, H3C2, H3C3, HNF1A, HRAS, IDH1, IDH2, IKZF1, ITPKB, JAK2, KDM6A, KDR, KEAP1, KIT, KMT2A, KRAS, MAP2K1, MAPK1, MDM2, MET, MEN1, MLH1, MLH3, MPL, MRE11, MSH2, MSH6, MTOR, MYC, MYCN, MYD88, NBN, NF1, NF2, NFE2L2, NOTCH1, NOTCH2, NPM1, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDGFRA, PDGFRB, PHF6, PIK3CA, PIK3CB, PIK3R1, PLCG2, POLE, POT1, PPP2R1A, PTCH1, PTEN, PTPN11, RAD21, RAD50, RAD51, RB1, RET, ROS1, RUNX1, SDHB, SDHC, SDHD, SETBP1, SETD2, SF3B1, SMAD4, SMARCB1, SMC1A, SMC3, SMO, SRSF2, STAG2, STAT3, STAT5B, STK11, TERT, TET2, TP53, TRAF7, TSC1, TSC2, U2AF1, VHL, WT1, ZRSR2

Genes analyzed for copy number variations (145 gene subset): ABL1, AKT1, ALK, APC, ARID1A, ARID2, ASXL1, ATM, ATR, AXL, B2M, BAP1, BIRC3, BLM, BRAF, BRCA1, BRCA2, CALR, CBL, CBLB, CCND1, CCND2, CCND3, CCNE1, CD274, CDH1, CDK4, CDK6, CDKN2A, CEBPA, CHEK1, CHEK2, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUX1, CXCR4, DAXX, DDR2, DDX41, DICER1, DNMT3A, EGFR, EP300, EPHA3, EPHA5, ERBB2, ERBB3, ERBB4, ERCC3, ESR1, ETV6, EZH2, FANCA, FAT3, FBXW7, FGFR1, FGFR2, FGFR3, FH, FLT3, FOXL2, GATA2, GNA11, GNAQ, GNAS, GRIN2A, H3-3A, H3C2, H3C3, HNF1A, HRAS, IDH1, IDH2, IKZF1, ITPKB, JAK2, KDR, KIT, KMT2A, KRAS, MAP2K1, MAPK1, MDM2, MET, MLH1, MLH3, MPL, MRE11, MSH2, MSH6, MTOR, MYC, MYCN, MYD88, NBN, NF1, NF2, NFE2L2, NOTCH1, NOTCH2, NPM1, NRAS, PALB2, PBRM1, PDGFRA, PDGFRB, PIK3CA, PIK3CB, PIK3R1, PLCG2, POLE, POT1, PPP2R1A, PTCH1, PTEN, PTPN11, RAD21, RAD51, RB1, RET, RUNX1, SDHB, SDHC, SDHD, SETBP1, SF3B1, SMAD4, SMARCB1, SMC3, SMO, SRSF2, STAT3, STAT5B, STK11, TERT, TET2, TP53, TSC1, TSC2, U2AF1, VHL, WT1

Genes analyzed for fusions/translocations (3): ALK, RET, and ROS1

CPT Codes

81450

Methodology

The test procedure involves DNA extraction and quantity/quality assessment, fragmentation and library preparation, followed by pooled capture targeting the desired genomic loci. Next generation sequencing (NGS) is performed on the Illumina platform and downstream analysis for quality control and detection of mutations is performed via custom-design bioinformatics pipelines on a HIPAA-compliant high performance computing system within the Center for Research Informatics (CRI).

Synonyms/Key Search Words

CNV, copy number, cancer, mutation, panel, NGS, NextGen, Sequencing, Gene